Till Kaemmerer, Benjamin Maximilian Clanner-Engelshofen, Tony Lesmeister, Lars Einar French & Markus Reinholz
October 18, 2022
Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities. Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis. In this open trial, we present the case of a refractory generalized hyperhidrosis treated with cannabinoids. We found a remarkable reduction in the volume of sweat and an improvement to the patient’s quality of life using this novel low-cost and low-impact approach.
Kaemmerer, T., Clanner-Engelshofen, B. M., Lesmeister, T., French, L. E., & Reinholz, M. (2022). Cannabinoids in hyperhidrosis. Journal of Dermatological Treatment, 1-3.